Growth Metrics

Biogen (BIIB) Construction in Progress (2016 - 2025)

Biogen (BIIB) has 16 years of Construction in Progress data on record, last reported at $163.1 million in Q4 2025.

  • For Q4 2025, Construction in Progress fell 47.11% year-over-year to $163.1 million; the TTM value through Dec 2025 reached $163.1 million, down 47.11%, while the annual FY2025 figure was $163.1 million, 47.11% down from the prior year.
  • Construction in Progress reached $163.1 million in Q4 2025 per BIIB's latest filing, down from $308.4 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $1.9 billion in Q1 2021 and bottomed at $163.1 million in Q4 2025.
  • Average Construction in Progress over 5 years is $754.1 million, with a median of $711.1 million recorded in 2022.
  • Peak YoY movement for Construction in Progress: rose 15.38% in 2022, then crashed 68.38% in 2024.
  • A 5-year view of Construction in Progress shows it stood at $770.3 million in 2021, then rose by 15.38% to $888.8 million in 2022, then rose by 9.74% to $975.4 million in 2023, then plummeted by 68.38% to $308.4 million in 2024, then plummeted by 47.11% to $163.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Construction in Progress were $163.1 million in Q4 2025, $308.4 million in Q4 2024, and $975.4 million in Q4 2023.